Erratum: Efficacy of transcatheter arterial chemoembolization-based multimodal treatment in patients with neuroendocrine tumors involving the liver

Erratum to: Transl Cancer Res 2025;14:4321-30.

In the published article entitled “Efficacy of transcatheter arterial chemoembolization-based multimodal treatment in patients with neuroendocrine tumors involving the liver” (Transl Cancer Res 2025;14:4321-30. doi: 10.21037/tcr-2024-2482) (1), authorship annotation was published incorrectly. The superscripted “#” to Rongxin Chen and Maopei Chen should be deleted.

The updated lineup of authorship should be read as follows.

Hu Xu^1#, Li Zhang^2#, Juan Zhang^3,4,5, Yi Chen^3,4,5, Ningling Ge^3,4,5, Yuhong Gan^3,4,5, Rongxin Chen^3,4,5, Maopei Chen^3,4,5

The authors apologize for any inconvenience that it may have caused.

Click here to view the updated version of the article.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

References

1. Xu H, Zhang L, Zhang J, et al. Efficacy of transcatheter arterial chemoembolization-based multimodal treatment in patients with neuroendocrine tumors involving the liver. Transl Cancer Res 2025;14:4321-30. [Crossref] [PubMed]